Survey of Ophthalmology
Volume 47, Issue 4 , Pages 297-334 , July 2002

Management of Traumatic Hyphema

  • William Walton, MD
    • ,
  • Stanley Von Hagen, PhD
    • ,
  • Ruben Grigorian, MD
    • ,
  • Marco Zarbin, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint address: Marco A. Zarbin, MD, PhD, Institute of Ophthalmology and Visual Science, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Rm. 6156, Doctors Office Center, 90 Bergen Street, PO Box 1709, Newark, NJ, 01701-1709, USA

References 

  1. Ablondi FB, DeRenzo EC. Mechanism of clot lysis by streptokinase and effects of epsilon-aminocaproic acid. Proc Soc Exp Biol Med. 1959;102:717–719
  2. Ablondi FB, Hagan JJ, Philips M, DeRenzo EC. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by epsilon-aminocaproic acid. Arch Biochem Biophys. 1959;82:153–160
  3. Ackerman J, Goldstein M, Kanarek I. Spontaneous massive vitreous hemorrhage secondary to thrombocytopenia. Ophthalmic Surg. 1980;11:636–637
  4. Agapitos PJ, Noel LP, Clarke WN. Traumatic hyphema in children. Ophthalmology. 1987;94:1238–1241
  5. Akpek EK, Gottsch JD. Herpes zoster sine herpete presenting with hyphema. Ocul Immunol Inflamm. 2000;8:115–118
  6. Alkjaersig N, Fletcher P, Sherry S. E-aminocaproic acid (an inhibitor of plasminogen activation). J Biol Chem. 1959;234:832–837
  7. Allingham RR, Crouch ER, Williams PB, et al.  Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model. Arch Ophthalmol. 1988;106:1436–1438
  8. Allingham RR, Williams PB, Crouch ER, et al.  Topically applied aminocaproic acid concentrates in the aqueous humor of the rabbit in therapeutic levels. Arch Ophthalmol. 1987;105:1421–1423
  9. Alper MG. Contusion angle deformity and glaucoma. Arch Ophthalmol. 1963;69:455–467
  10. Arentsen JJ, Green WR. Melanoma of the iris (report of 72 cases treated surgically). Ophthalmic Surg. 1975;6:23–37
  11. Aylward GW, Dunlop IS, Little BC. Meta-analysis of systemic anti-fibrinolytics in traumatic hyphaema. Eye. 1994;8:440–442
  12. Becker B. The effects of the carbonic anhydrase inhibitor, acetazolamide, on the composition of the aqueous humor. Am J Ophthalmol. 1955;40:129–136
  13. Bedrossian RH. The management of traumatic hyphema. Ann Ophthalmol. 1974;6:1016–10181020–1,
  14. Behrendt H, Wenniger-Prick LM. Leukemic iris infiltration as the only site of relapse in a child with acute lymphoblastic leukemia (temporary remission with high-dose chemotherapy). Med Pediatr Oncol. 1985;13:352–356
  15. Bengtsson E, Ehinger B. Treatment of traumatic hyphaema. Acta Ophthalmol (Copenh). 1975;53:914–923
  16. Beyer TL, Hirst LW. Corneal blood staining at low pressures. Arch Ophthalmol. 1985;103:654–655
  17. Blanksma LJ, Hooijmans JM. Vascular tufts of the pupillary border causing a spontaneous hyphaema. Ophthalmologica. 1979;178:297–302
  18. Blanton FM, Pollack IP. Therapy of open angle glaucoma. Arch Ophthalmol. 1966;75:763–767
  19. Bloom JN. Traumatic hyphema in children. Pediatr Ann. 1990;19:368–371375,
  20. Bourne WM. No statistically significant difference. So what?. Arch Ophthalmol. 1987;105:40–41
  21. Bramsen T. Fibrinolysis and traumatic hyphaema. Acta Ophthalmol (Copenh). 1979;57:447–454
  22. Bramsen T. Traumatic eye hemorrhage (hyphema) treated with the antifibrinolytic preparation tranexamic acid. Ugeskr Laeger. 1977;54:250–256
  23. Bramsen T. Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid II. Acta Ophthalmol (Copenh). 1977;55:616–620
  24. Brenkman RF, Oosterhuis JA, Manschot WA. Recurrent hemorrhage in the anterior chamber caused by a (juvenile) xanthogranuloma of the iris in an adult. Doc Ophthalmol. 1977;42:329–333
  25. Britt CW, Light RR, Peters BH, Schochet SS. Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Arch Neurol. 1980;37:187–188
  26. Britten MJA. Follow-up of 54 cases of ocular contusion with hyphema. Br J Ophthalmol. 1965;49:120–127
  27. Brodkin HM. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report. J Neurosurg. 1980;53:690–692
  28. Brodrick JD. Corneal blood staining after hyphaema. Br J Ophthalmol. 1972;56:589–593
  29. Bruner WE, Stark WJ, Green WR. Presumed juvenile xanthogranuloma of the iris and ciliary body in an adult. Arch Ophthalmol. 1982;100:457–459
  30. Cahn PH, Havener WH. Factors of importance in traumatic hyphema with particular reference to and study of routes of absorption. Am J Ophthalmol. 1963;55:591–597
  31. Campbell DG. Ghost cell glaucoma following trauma. Ophthalmology. 1981;88:1151–1158
  32. Campbell DG, Simmons RJ, Grant WM. Ghost cells as a cause of glaucoma. Am J Ophthalmol. 1976;81:441–450
  33. Canavan YM, Archer DB. Anterior segment consequences of blunt ocular injury. Br J Ophthalmol. 1982;66:549–555
  34. Cassel GH, Jeffers JB, Jaeger EA. Wills Eye Hospital Traumatic Hyphema Study. Ophthalmic Surg. 1985;16:441–443
  35. Cho J, Jun BK, Yee YJ. Factors associated with poor visual outcome after traumatic hyphema. Korean J Ophthalmol. 1998;12:122–129
  36. Clarke WN, Noel LP. Outpatient treatment of microscopic and rim hyphemas in children with tranexamic acid. Can J Ophthalmol. 1993;28:325–327
  37. Clever VG. Home care of hyphemas. Ann Ophthalmol. 1982;14:25–27
  38. Coats DK, Paysse EA, Kong J. Unrecognized microscopic hyphema masquerading as a closed head injury. Pediatrics. 1998;102:652–654
  39. Coats DK, Viestenz A, Paysse EA, Plager DA. Outpatient management of traumatic hyphemas in children. Binocul Vis Strabismus Q. 2000;15:169–174
  40. Cobb B, Shilling JS, Chisholm IH. Vascular tufts at the pupillary margin in myotonic dystrophy. Am J Ophthalmol. 1970;69:573–582
  41. Cohen SB, Fletcher ME, Goldberg MF, Jednock NJ. Diagnosis and management of ocular complications of sickle hemoglobinopathies (Part V). Ophthalmic Surg. 1986;17:369–374
  42. Cole JG, Byron HM. Evaluation of 100 eyes with traumatic hyphema (intravenous urea). Arch Ophthalmol. 1964;71:35–43
  43. Coleman SL, Green WR, Patz A. Vascular tufts of pupillary margin of iris. Am J Ophthalmol. 1977;83:881–883
  44. Coles WH. Traumatic hyphema (an analysis of 235 cases). South Med J. 1968;61:813–816
  45. Crawford JS, Lewandowski RL, Chan W. The effect of aspirin on rebleeding in traumatic hyphema. Am J Ophthalmol. 1975;80:543–545
  46. Crouch ER, Crouch ER. Management of traumatic hyphema (therapeutic options). J Pediatr Ophthalmol Strabismus. 1999;36:238–250quiz 279–80
  47. Crouch ER, Frenkel M. Aminocaproic acid in the treatment of traumatic hyphema. Am J Ophthalmol. 1976;81:355–360
  48. Crouch ER Jr, Williams PB: Trauma: ruptures and bleeding, in Tasman W, Jaeger EM (eds): Duane's Clinical Ophthalmology. Philadelphia; JB Lippincott, 1993, pp 1–18
  49. Crouch ER, Williams PB, Gray MK, et al.  Topical aminocaproic acid in the treatment of traumatic hyphema. Arch Ophthalmol. 1997;115:1106–1112
  50. Darr JL, Passmore JW. Management of traumatic hyphema. Am J Ophthalmol. 1967;63:134–136
  51. de Bustros S, Glaser BM, Michels RG, Auer C. Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage. Arch Ophthalmol. 1985;103:219–221
  52. Deans R, Noel LP, Clarke WN. Oral administration of tranexamic acid in the management of traumatic hyphema in children. Can J Ophthalmol. 1992;27:181–183
  53. DeRespinis PA, Caputo AR, Fiore PM, Wagner RS. A survey of severe eye injuries in children. Am J Dis Child. 1989;143:711–716
  54. Deutsch TA, Weinreb RN, Goldberg MF. Indications for surgical management of hyphema in patients with sickle cell trait. Arch Ophthalmol. 1984;102:566–569
  55. Diddie KR, Dinsmore S, Murphree AL. Total hyphema evacuation by vitrectomy instrumentation. Ophthalmology. 1981;88:917–921
  56. Dieste MC, Hersh PS, Kylstra JA, et al.  Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema. Am J Ophthalmol. 1988;106:383–390
  57. Driver PJ, Cashwell LF, Yeatts RP. Airbag-associated bilateral hyphemas and angle recession. Am J Ophthalmol. 1994;118:250–251
  58. Duke-Elder S, Leigh AG. System of Ophthalmology, Part II, Vol VII (Diseases of the Outer Eye). London: Henry Kimpton; 1965;pp 982–4
  59. Duke-Elder S, MacFaul PA. System of Ophthalmology, Part I, Vol XIV (Mechanical Injuries). London: Henry Kimpton; 1972;pp 93–101
  60. Eagling EM. Ocular damage after blunt trauma to the eye. Its relationship to the nature of the injury. Br J Ophthalmol. 1974;58:126–140
  61. Ederer F. Refereeing clinical research papers for statistical content. Am J Ophthalmol. 1985;100:735–737
  62. Edson JR, Krivit W, White JG. Kaolin partial thromboplastin time (high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants). J Lab Clin Med. 1967;70:463–470
  63. Edwards WC, Layden WE. Traumatic hyphema. A report of 184 consecutive cases. Am J Ophthalmol. 1973;75:110–116
  64. Ehlers WH, Crouch ER, Williams PB, Riggs PK. Factors affecting therapeutic concentration of topical aminocaproic acid in traumatic hyphema. Invest Ophthalmol Vis Sci. 1990;31:2389–2394
  65. Farber MD, Fiscella R, Goldberg MF. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial. Ophthalmology. 1991;98:279–286
  66. Ferguson RHL, Poole LW. Traumatic hyphema (preliminary report on 200 cases). Trans Ophthalmol Soc NZ. 1968;20:54–62
  67. Finch CA. Pathophysiologic aspects of sickle cell anemia. Am J Med. 1972;53:1–6
  68. Fong LP. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis. Ophthalmology. 1994;101:1583–1588
  69. Fritch CD. Traumatic hyphema. Ann Ophthalmol. 1976;8:1223–1225
  70. Geeraets WJ, Liu C-H, Guerry D. Traumatic hyphema (a review of experience at the Medical College of Virginia during the past decade). MCV Quarterly. 1967;3:20–25
  71. Gilbert HD, Jensen AD. Atropine in the treatment of traumatic hyphema. Ann Ophthalmol. 1973;5:1297–1300
  72. Gillan JG. Treatment and prophylaxis of hyphaema by conjugated estrogens. Trans Can Ophth Soc. 1961;24:217–222
  73. Goldberg JL. Conjugated estrogens in the prevention of secondary hyphema after ocular trauma. Arch Ophthalmol. 1960;63:1001–1004
  74. Goldberg MF. The diagnosis and treatment of secondary glaucoma after hyphema in sickle cell patients. Am J Ophthalmol. 1979;87:43–49
  75. Goldberg MF. The diagnosis and treatment of sickled erythrocytes in human hyphemas. Trans Am Ophthalmol Soc. 1978;76:481–501
  76. Goldberg MF, Dizon R, Moses VK. Sickled erythrocytes, hyphema, and secondary glaucoma (VI. The relationship between intracameral blood cells and aqueous humor pH, PO2, and PCO2). Ophthalmic Surg. 1979;10:78–88
  77. Goldberg MF, Dizon R, Raichand M, Goldbaum M. Sickled erythrocytes, hyphema and secondary glaucoma (III. Effects of sickle cell and normal human blood samples in rabbit anterior chambers). Ophthalmic Surg. 1979;10:52–61
  78. Goldberg MF, Tso MO. Sickled erythrocytes, hyphema, and secondary glaucoma (VII. The passage of sickled erythrocytes out of the anterior chamber of the human and monkey eye: light and electron microscopic studies). Ophthalmic Surg. 1979;10:89–123
  79. Gorn RA. The detrimental effect of aspirin on hyphema rebleed. Ann Ophthalmol. 1979;11:351–355
  80. Gottsch JD. Hyphema (diagnosis and management). Retina. 1990;10(Suppl 1):S65–S71
  81. Gottsch JD, Graham CR, Hairston RJ, et al.  Protoporphyrin IX photosensitization of corneal endothelium. Arch Ophthalmol. 1989;107:1497–1500
  82. Gottsch JD, Messmer EP, McNair DS, Font RL. Corneal blood staining. An animal model. Ophthalmology. 1986;93:797–802
  83. Graul TA, Ruttum MS, Lloyd MA, et al.  Trabeculectomy for traumatic hyphema with increased intraocular pressure. Am J Ophthalmol. 1994;117:155–159
  84. Gregersen E. Traumatic hyphema II. Acta Ophthalmol (Copenh). 1962;40:200–201
  85. Gregersen E. Traumatic hyphema I. Acta Ophthalmol (Copenh). 1962;40:192–199
  86. Griffin JD, Ellman L. Epsilon-aminocaproic acid (EACA). Semin Thromb Hemost. 1978;5:27–40
  87. Hagger D, Wolff S, Owen J, Samson D. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Blood Coagul Fibrinolysis. 1995;6:93–99
  88. Hallet C, Willoughby C, Shafiq A, et al.  Pitfalls in the management of a child with mild haemophilia A and a traumatic hyphaema. Haemophilia. 2000;6:118–119
  89. Henry MM. Nonperforating eye injuries with hyphema. Am J Ophthalmol. 1960;49:1298–1300
  90. Hogan MJ, Zimmerman LE. Ophthalmic Pathology (an Atlas and Textbook). WB Saunders: Philadelphia; 1962;ed 2, pp 332–3
  91. Horven I. Erythrocyte resorption from the anterior chamber of the human eye. Acta Ophthalmol Scand. 1963;41:402–412
  92. Howard GM, Hutchinson BT, Fredrick AR. Hyphema resulting from blunt trauma—gonioscopic, tonographic, and ophthalmoscopic observation following resolution of the hemorrhage. Trans Am Acad Ophthalmol Otolaryngol. 1965;69:294–306
  93. Howard GR, Vukich J, Fiscella RG, et al.  Intraocular tissue plasminogen activator in a rabbit model of traumatic hyphema. Arch Ophthalmol. 1991;109:272–274
  94. Jarstad JS, Hardwig PW. Intraocular hemorrhage from wound neovascularization years after anterior segment surgery (Swan syndrome). Can J Ophthalmol. 1987;22:271–275
  95. Kageler WV, Moake JL, Garcia CA. Spontaneous hyphema associated with ingestion of aspirin and ethanol. Am J Ophthalmol. 1976;82:631–634
  96. Kanai A, Yamaguchi T, Okisaka S, Nakajima A. An analytical electron microscopic study of the corneal and conjunctival deposits of pigments and other substances. Part 4 (Hematogenous pigmentation). Folia Ophthalmologica Jpn. 1977;28:956–965
  97. Kaufman JH, Tolpin DW. Glaucoma after traumatic angle recession. A ten-year prospective study. Am J Ophthalmol. 1974;78:648–654
  98. Kearns P. Traumatic hyphaema (a retrospective study of 314 cases). Br J Ophthalmol. 1991;75:137–141
  99. Kennedy RH, Brubaker RF. Traumatic hyphema in a defined population. Am J Ophthalmol. 1988;106:123–130
  100. Kim MH, Koo TH, Sah WJ, Chung SM. Treatment of total hyphema with relatively low-dose tissue plasminogen activator. Ophthalmic Surg Lasers. 1998;29:762–766
  101. Kitazawa Y. Management of traumatic hyphema with glaucoma. Int Ophthalmol Clin. 1981;21:167–181
  102. Kobayashi H, Honda Y: Intraocular hemorrhage in a patient with hemophilia. Metab Ophthalmol 8:27–30, 1984–85
  103. Koehler MP, Sholiton DB. Spontaneous hyphema resulting from warfarin. Ann Ophthalmol. 1983;15:858–859
  104. Kraft SP, Christianson MD, Crawford JS, et al.  Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid. Ophthalmology. 1987;94:1232–1237
  105. Kurz GH, Zimmerman LE. Spontaneous hyphema and acute glaucoma as initial signs of recurrent iris melanoma. Arch Ophthalmol. 1963;69:581–582
  106. Kushner AG. Traumatic hyphema. Surv Ophthalmol. 1959;4:2–19
  107. Kushner BJ. The use and abuse of statistics. Binocular Vision. 1986;1:188–190
  108. Kutner B, Fourman S, Brein K, et al.  Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema. Arch Ophthalmol. 1987;105:206–208
  109. Laatikainen L, Mattila J. The use of tissue plasminogen activator in post-traumatic total hyphaema. Graefes Arch Clin Exp Ophthalmol. 1996;234:67–68
  110. Lai JC, Fekrat S, Barron Y, Goldberg MF. Traumatic hyphema in children (risk factors for complications). Arch Ophthalmol. 2001;119:64–70
  111. Lai WW, Bhavnani VD, Tessler HH, Edward DP. Effect of melanin on traumatic hyphema in rabbits. Arch Ophthalmol. 1999;117:789–793
  112. Lambrou FH, Snyder RW, Williams GA. Use of tissue plasminogen activator in experimental hyphema. Arch Ophthalmol. 1987;105:995–997
  113. Larsson LI, Alm A. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide. Arch Ophthalmol. 1998;116:19–24
  114. Laughlin RC. Anterior chamber hemorrhage in nonperforating injuries. Trans Pac Coast Otoophthalmol Soc Annu Meet. 1948;29:133–140
  115. Lawrence T, Wilison D, Harvey J. The incidence of secondary hemorrhage after traumatic hyphema. Ann Ophthalmol. 1990;22:276–278
  116. Leet DM. Treatment of total hyphemas with urokinase. Am J Ophthalmol. 1977;84:79–84
  117. Leone CR. Traumatic hyphema in children. J Pediatr Ophthalmol. 1966;3:7–13
  118. Lifschitz T, Yermiahu T, Biedner B, Yassur Y. Traumatic total hyphema in a patient with severe hemophilia. J Pediatr Ophthalmol Strabismus. 1986;23:80–81
  119. Little BC, Aylward GW. The medical management of traumatic hyphaema (a survey of opinion among ophthalmologists in the UK). J R Soc Med. 1993;86:458–459
  120. Loewy DM, Williams PB, Crouch ER, Cooke WJ. Systemic aminocaproic acid reduces fibrinolysis in aqueous humor. Arch Ophthalmol. 1987;105:272–276
  121. Loring MJ. Traumatic hyphema. Am J Ophthalmol. 1958;45:873–880
  122. MacKay AR, Sang UH, Weinstein PR. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. J Neurosurg. 1978;49:597–601
  123. Magargal LE, Goldberg RE, Uram M, et al.  Recurrent microhyphema in the pseudophakic eye. Ophthalmology. 1983;90:1231–1234
  124. Manschot WA. Blood staining of the cornea. Ophthalmologica. 1947;113:203–214
  125. Marcus M, Biedner B, Lifshitz T, Yassur Y. Aspirin and secondary bleeding after traumatic hyphema. Ann Ophthalmol. 1988;20:157–158
  126. Maurice DM: The use of permeability studies in the investigation of submicroscopic structure, in Smelser GK (ed): The Structure of the Eye; Proceedings of the Symposium April 11–13, 1960 during the Seventh International Congress of Anatomists, NY, NY. Baltimore, Academic Press, 1961, pp 281–91
  127. McCuen BW, Fung WE. The role of vitrectomy instrumentation in the treatment of severe traumatic hyphema. Am J Ophthalmol. 1979;88:930–934
  128. McDonald CJ, Raafat A, Mills MJ, Rumble JA. Medical and surgical management of spontaneous hyphaema secondary to immune thrombocytopenia. Br J Ophthalmol. 1989;73:922–925
  129. McDonnell PJ, Green WR, Stevens RE, et al.  Blood staining of the cornea. Light microscopic and ultrastructural features. Ophthalmology. 1985;92:1668–1674
  130. McGetrick JJ, Jampol LM, Goldberg MF, et al.  Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema. Arch Ophthalmol. 1983;101:1031–1033
  131. McNicol GP, Fletcher AP, Alkjaersig N. The absorption, distribution and excretion of e-aminocaproic acid following oral or intravenous administration. J Lab Clin Med. 1962;59:15–24
  132. Messmer EP, Gottsch JD, Font RL. Blood staining of the cornea (a histopathologic analysis of 16 cases). Cornea. 1985;3:205–212
  133. Michels RG, Rice TA. Bimanual bipolar diathermy for treatment of bleeding from the anterior chamber angle. Am J Ophthalmol. 1977;84:873–874
  134. Michelson PE, Pfaffenbach D. Retinal arterial occlusion following ocular trauma in youths with sickle-trait hemoglobinopathy. Am J Ophthalmol. 1972;74:494–497
  135. Milauskas AT, Fueger GF. Serious ocular complications associated with blowout fractures of the orbit. Am J Ophthalmol. 1966;62:670–672
  136. Mishler KE. Hyphema caused by airbag. Arch Ophthalmol. 1991;109:1635
  137. Missotten L, De Clippeleir L, Van Tornout I, Beenders P. The value of tranexamic acid (cyklokapron) in the prevention of secondary bleeding, a complication of traumatic hyphaemia. Bull Soc Belge Ophtalmol. 1977;179:47–52
  138. Mooney D. Angle recession and secondary glaucoma. Br J Ophthalmol. 1973;57:608–612
  139. Morsman CD, Holmes J. Traumatic hyphaema in a haemophiliac. Br J Ophthalmol. 1990;74:563
  140. Mortensen KK, Sjolie AK. Secondary haemorrhage following traumatic hyphaema. A comparative study of conservative and tranexamic acid treatment. Acta Ophthalmol (Copenh). 1978;56:763–768
  141. Nasrullah A, Kerr NC. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema. Am J Ophthalmol. 1997;123:783–790
  142. Ng CS, Sparrow JM, Strong NP, Rosenthal AR. Factors related to the final visual outcome of 425 patients with traumatic hyphema. Eye. 1992;6:305–307
  143. Ng CS, Strong NP, Sparrow JM, Rosenthal AR. Factors related to the incidence of secondary haemorrhage in 462 patients with traumatic hyphema. Eye. 1992;6:308–312
  144. Nicholson DH. Occult iris erosion. A treatable cause of recurrent hyphema in iris- supported intraocular lenses. Ophthalmology. 1982;89:113–120
  145. Ohrstrom A. Treatment of traumatic hyphaema with corticosteroids and mydriatics. Acta Ophthalmol (Copenh). 1972;50:549–555
  146. Okamoto S, Nakajima T, Okamoto U. A suppressing effect of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity. Surg Forum. 1968;19:413–414
  147. Oksala A. Treatment of traumatic hyphaema. Br J Ophthalmol. 1967;51:315–320
  148. Pakalnis VA, Rustgi AK, Stefansson E, et al.  The effect of timolol on anterior-chamber oxygenation. Ann Ophthalmol. 1987;19:298–300
  149. Palmer DJ, Goldberg MF, Frenkel M, et al.  A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas. Ophthalmology. 1986;93:102–108
  150. Pandolfi M, Nilsson IM, Nilehn JE. On intraocular fibrinolysis. Thromb Diath Haemorrh. 1966;15:161–172
  151. Parsons MR, Merritt DR, Ramsay RC. Retinal artery occlusion associated with tranexamic acid therapy. Am J Ophthalmol. 1988;105:688–689
  152. Physicians Desk Reference. Montvale, NJ, Medical Economics, 2000
  153. Pieramici DJ, Goldberg MF, Melia BM. Topical aminocaproic acid (Caprogel) in the treatment of traumatic hyphema (results of a phase III multicenter placebo controlled trial). Invest Ophthalmol Vis Sci. 2000;41(Suppl):S306;[abstract]
  154. Pitts TO, Spero JA, Bontempo FA, Greenberg A. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid. Am J Kidney Dis. 1986;8:441–444
  155. Pouliquen Y, Desvignes P: [Ultrastructure of a hematocornea]. Arch Ophtalmol Rev Gen Ophtalmol 27:45–52, 1967
  156. Radius RL, Finkelstein D. Central retinal artery occlusion (reversible in sickle trait) with glaucoma. Br J Ophthalmol. 1976;60:428–430
  157. Rahmani B, Jahadi HR. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. Ophthalmology. 1999;106:375–379
  158. Rahmani B, Jahadi HR, Rajaeefard A. An analysis of risk for secondary hemorrhage in traumatic hyphema. Ophthalmology. 1999;106:380–385
  159. Rakusin W. Traumatic hyphema. Am J Ophthalmol. 1972;74:284–292
  160. Read J. Traumatic hyphema (surgical vs medical management). Ann Ophthalmol. 1975;7:659–662664–6, 668–70,
  161. Read J, Goldberg MF. Comparison of medical treatment for traumatic hyphema. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:799–815
  162. Romano PE. Traumatic hyphema management (assuring compliance with outpatient care; steroidophobia: rational or irrational?). Binocul Vis Strabismus Q. 2000;15:166–168
  163. Romano PE. Systemic prednisolone prevents rebleeding in traumatic hyphema. Ophthalmology. 2000;107:812–814
  164. Romano PE. Pro steroids for systemic antifibrinolytic treatment for traumatic hyphema. J Pediatr Ophthalmol Strabismus. 1986;23:92–95
  165. Romano PE. Management of traumatic hyphema. Perspect Ophthalmol. 1981;5:33–38
  166. Romano PE, Hope GM. The effect of age and ethnic background on the natural rebleed rate in untreated traumatic hyphema in children. Metab Pediatr Syst Ophthalmol. 1990;13:26–31
  167. Romano PE, Phillips PJ. Traumatic hyphema (a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol). Binocul Vis Strabismus Q. 2000;15:187–196
  168. Romano PE, Robinson JA. Traumatic hyphema (a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (p < .0001)). Binocul Vis Strabismus Q. 2000;15:175–186
  169. Rynne MV, Romano PE. Systemic corticosteroids in the treatment of traumatic hyphema. J Pediatr Ophthalmol Strabismus. 1980;17:141–143
  170. Scheie HG, Ashley BJ, Burns DT. Treatment of total hyphema with fibrinolysin. Arch Ophthalmol. 1963;69:147–153
  171. Schiff FS. Coumadin related spontaneous hyphemas in patients with iris fixated pseudophakos. Ophthalmic Surg. 1985;16:172–173
  172. Sears ML. Surgical management of black ball hyphema. Trans Am Acad Ophthalmol Otolaryngol. 1970;74:820–825
  173. Shammas HF, Matta CS. Outcome of traumatic hyphema. Ann Ophthalmol. 1975;7:701–706
  174. Sharpe ED, Simmons RJ. Argon laser therapy of occult recurrent hyphema from anterior segment wound neovascularization. Ophthalmic Surg. 1986;17:283–285
  175. Shea M. Traumatic hyphema in children. Can Med Assoc J. 1957;76:466–469
  176. Shiuey Y, Lucarelli MJ. Traumatic hyphema (outcomes of outpatient management). Ophthalmology. 1998;105:851–855
  177. Sinskey RM, Krichesky A, Henrickson R. Am J Ophthalmol. 1957;43:292
  178. Sjolie AK, Mortensen KK. Traumatic hyphaema treated ambulatory and without antifibrinolytic drugs. Acta Ophthalmol (Copenh). 1980;58:125–128
  179. Skalka HW. Recurrent hemorrhage in traumatic hyphema. Ann Ophthalmol. 1978;10:1153–1157
  180. Smith HE. Anterior chamber hemorrhages following nonperforating ocular injuries. Rocky Mt Med J. 1952;49:844–848
  181. Snir M, Axer-Siegel R, Buckman G, Yassur Y. Central venous stasis retinopathy following the use of tranexamic acid. Retina. 1990;10:181–184
  182. Sorr EM, Goldberg RE. Traumatic central retinal artery occlusion with sickle cell trait. Am J Ophthalmol. 1975;80:648–652
  183. Spaeth GL, Levy PM. Traumatic hyphema (its clinical characteristics and failure of estrogens to alter its course. A double-blind study). Am J Ophthalmol. 1966;62:1098–1106
  184. Speakman JS. Recurrent hyphema after surgery. Can J Ophthalmol. 1975;10:299–304
  185. Spoor TC, Hammer M, Belloso H. Traumatic hyphema. Failure of steroids to alter its course (a double- blind prospective study). Arch Ophthalmol. 1980;98:116–119
  186. Spoor TC, Kwitko GM, OGrady JM, Ramocki JM. Traumatic hyphema in an urban population. Am J Ophthalmol. 1990;109:23–27
  187. Starck T, Hopp L, Held KS, et al.  Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes. J Cataract Refract Surg. 1995;21:219–224
  188. Stern WH, Mondal KM. Vitrectomy instrumentation for surgical evacuation of total anterior chamber hyphema and control of recurrent anterior chamber hemorrhage. Ophthalmic Surg. 1979;10:34–37
  189. Swan KC. Late hyphema due to wound vascularization. Trans Am Acad Ophthalmol Otolaryngol. 1976;81:OP138–OP144
  190. Swan KC. Hyphema due to wound vascularization after cataract extraction. Arch Ophthalmol. 1973;89:87–90
  191. Teboul BK, Jacob JL, Barsoum-Homsy M, et al.  Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children. Ophthalmology. 1995;102:1646–1653
  192. Theriault FA, Pearce WG. Incidence of accommodative impairment following traumatic hyphema. Can J Ophthalmol. 1993;28:263–265
  193. Thomas MA, Parrish RK, Feuer WJ. Rebleeding after traumatic hyphema. Arch Ophthalmol. 1986;104:206–210
  194. Thygeson P, Beard C. Observations in traumatic hyphema. Am J Ophthalmol. 1952;35:977–985
  195. Tonjum AM. Intraocular pressure and facility of outflow late after ocular contusion. Acta Ophthalmol (Copenh). 1968;46:886–908
  196. Tonjum AM. Gonioscopy in traumatic hyphema. Acta Ophthalmol (Copenh). 1966;44:650–664
  197. Uusitalo RJ, Ranta-Kemppainen L, Tarkkanen A. Management of traumatic hyphema in children. An analysis of 340 cases. Arch Ophthalmol. 1988;106:1207–1209
  198. Uusitalo RJ, Saari MS, Aine E, Saari KM. Tranexamic acid in the prevention of secondary haemorrhage after traumatic hyphaema. Acta Ophthalmol (Copenh). 1981;59:539–545
  199. Vangsted P, Nielsen PJ. Tranexamic acid and traumatic hyphaema. A prospective study. Acta Ophthalmol (Copenh). 1983;61:447–453
  200. Varnek L, Dalsgaard C, Hansen A, Klie F. The effect of tranexamic acid on secondary haemorrhage after traumatic hyphaema. Acta Ophthalmol (Copenh). 1980;58:787–793
  201. Verma N. Trabeculectomy and manual clot evacuation in traumatic hyphaema with corneal blood staining. Aust NZ J Ophthalmol. 1996;24:33–38
  202. Vernot JA, Barron BA, Goldberg MF. Effects of topical epinephrine on experimental sickle cell hyphema. Arch Ophthalmol. 1985;103:280–283
  203. Volpe NJ, Larrison WI, Hersh PS, et al.  Secondary hemorrhage in traumatic hyphema. Am J Ophthalmol. 1991;112:507–513
  204. Watzke RC. Intraocular hemorrhage from vascularization of the cataract incision. Ophthalmology. 1980;87:19–23
  205. Wax MB, Ridley ME, Magargal LE. Reversal of retinal and optic disc ischemia in a patient with sickle cell trait and glaucoma secondary to traumatic hyphema. Ophthalmology. 1982;89:845–851
  206. Weiss JS, Parrish RK, Anderson DR. Surgical therapy of traumatic hyphema. Ophthalmic Surg. 1983;14:343–345
  207. Wilkerson M, Cyrlin M, Lippa EA, et al.  Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1993;111:1343–1350
  208. Williams C, Laidlaw A, Diamond J, et al.  Outpatient management of small traumatic hyphaemas (is it safe?). Eye. 1993;7:155–157
  209. Williams DF, Han DP, Abrams GW. Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator. Arch Ophthalmol. 1990;108:264–266
  210. Wilson FM. Traumatic hyphema. Pathogenesis and management. Ophthalmology. 1980;87:910–919
  211. Wilson TW, Jeffers JB, Nelson LB. Aminocaproic acid prophylaxis in traumatic hyphema. Ophthalmic Surg. 1990;21:807–809
  212. Wilson TW, Nelson LB, Jeffers JB, Manley DR. Outpatient management of traumatic microhyphemas. Ann Ophthalmol. 1990;22:366–368
  213. Witteman GJ, Brubaker SJ, Johnson M, Marks RG: The incidence of rebleeding in traumatic hyphema. Ann Ophthalmol 17:525–6, 528–9, 1985
  214. Wolf FM. Meta-analysis—Quantitative Methods for Research Synthesis. Sage University Paper # 59 (Series: Quantitative Applications in the Social Sciences). Thousand Oaks, CA, Sage Publications, Inc., 1986, pp 1–72
  215. Wolter JR, Henderson JW, Talley TW. Histopathology of a black ball blood clot removed four days after total traumatic hyphema. J Pediatr Ophthalmol Strabismus. 1971;8:15–18
  216. Wright KW, Sunalp M, Urrea P. Bed rest versus activity ad lib in the treatment of small hyphemas. Ann Ophthalmol. 1988;20:143–145
  217. Yasuna E. Management of traumatic hyphema. Arch Ophthalmol. 1974;91:190–191
  218. Yoshimura M, Sameshima M, Fujita S, Ohba N. Blood staining of the cornea in Hansens disease. A light- and electron- microscopic study. Ophthalmologica. 1980;181:314–319
  219. Zetterstrom B. The treatment of contusion of the eye. Acta Ophthalmol (Copenh). 1969;47:784–791

PII: S0039-6257(02)00317-X

Survey of Ophthalmology
Volume 47, Issue 4 , Pages 297-334 , July 2002

Article Tools

* Image Usage & Resolution